Companies we work with
Companies we work with
m
Transactions
%
Biotech / Medtech / Digital Health / Diagnostic
Cross-Borders Transactions

Cross-Borders Transactions

%
Public Equity
%
Private Equity Deals
Cross-Borders Transactions

Cross-Borders Transactions

Agile Capital Markets

M
Transactions
%
Biotech / Medtech / Digital Health / Diagnostic

Cross-Borders Transactions

%
Public Equity
%
Private Equity Deals

Our Recognition

Over 30 high quality professionally designed pre-built website concepts to choose from. Build your website using a fully visual interface, using our revolutionary page & header builder.

Established In
Projects
Clients

Agile Capital Markets

m
Transactions

%
Biotech / Medtech / Digital Health / Diagnostic

Cross-Borders Transactions

%
Public Equity

%
Private Equity Deals

Our Recognition

Over 30 high quality professionally designed pre-built website concepts to choose from. Build your website using a fully visual interface, using our revolutionary page & header builder.

Established In
Projects
Clients

Agile Capital Markets

m€
Transactions
%
Biotech / Medtech / Digital Health
Cross-Borders Transactions
%
Public Equity
%
Private Equity Deals

Our Recognition

Over 30 high quality professionally designed pre-built website concepts to choose from. Build your website using a fully visual interface, using our revolutionary page & header builder.

Established In
Projects
Clients

Capital Markets is a Fundraising & M&A Boutique for High Potential Life Science Companies.

Agile Capital Markets in a nutshell:

      • €300M+ secured. Size of transactions from €2.5M to €60M
      • 1,000+ investors can be reached; WW spread
      • 90% of transactions with international syndications
      • For both Private & Public Equity
      • Client satisfaction: +40% of customers performed more than one deal with us
      • Exclusively for Biotech, Medtech, Digital Health & Diagnostic companies

Our services include but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), Secondary offering, Strategic advice, Business model and Business planning.

Agile Capital Markets in a nutshell:

  • €300M+ secured. Size of transactions from €2.5M to €60M

  • 1,000+ investors can be reached; WW spread

  • 90% of transactions with international syndications

  • For both Private & Public Equity

  • Client satisfaction: +40% of customers performed more than one deal with us

  • Exclusively for Biotech, Medtech, Digital Health & Diagnostic companies

Our services include but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), Secondary offering, Strategic advice, Business model and Business planning.

Agile Capital Markets in a nutshell:

  • €300M+ secured. Size of transactions from €2.5M to €60M

  • 1,000+ investors can be reached; WW spread

  • 90% of transactions with international syndications

  • For both Private & Public Equity

  • Client satisfaction: +40% of customers performed more than one deal with us

  • Exclusively for Biotech, Medtech, Digital Health & Diagnostic companies

Our services include but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), Secondary offering, Strategic advice, Business model and Business planning.

TRANSACTIONS

Some of our disclosed transactions

Some of our Discloses Transactions

€15M

PIPE Euronext

with Fosun Pharma

€22M

Series B

$20M

Series B

Led by Chinese Medical Device company

€30M

Private Placement

Convertible Bonds

€2,5M

Private Funding

Led by Financière Arbevel

 

€20M

Debt

European Investment Bank

€2,25M

Series A

with German Investor

€17M

PIPE Euronext

€60M

Licensing Deal

with Chinese Investor

 

€10M

M&A Deal + PIPE

€6.5M

PIPE Euronext

 

Series B

TRANSACTIONS

Some of our Disclosed Transactions

Some of our Discloses Transactions

PIPE Euronext
with Fosun Pharma

Series B

Series B
lead by Chinese Medical Device company

Private Placement
Convertible Bonds

Private Funding
with French Investor

Private Placement
Convertible Bonds

PIPE Euronext

Series A
with German Investor

Series B

PIPE Euronext

M&A Deal + PIPE

Licensing Deal
with Chinese Investor

TRANSACTIONS

Some of our Disclosed Transactions

Some of our Discloses Transactions

€1,5M

PIPE Euronext
with Fosun Pharma

€22M

Series B

$20M

Series B lead by Chinese Medical Device company

€30M

Private Placement Convertible Bonds

€2,5M

Private Funding with French Investor

€20M

European Investment Bank Debt

€2,25M

Series A with German Investor

€17M

PIPE Euronext

€60M

Licensing Deal with Chinese Investor

€10M

M&A Deal + PIPE

€6.5M

PIPE Euronext

€1,5M

Series B

View All Transactions...

ABOUT US

OUR PHILOSOPHY

Our background as C-Level executives within the industry is an insurance that we will be able to understand the challenges entrepreneurs are facing. Our aim is to build long term relationships with our clients and to play a key role in achieving financial milestones as well as building the most efficient strategy for our client.

OUR DNA

Agile Capital Markets has built a team of passionate and committed professionals, with one singularity: they all show successful track records in the industry as private or listed companies’ CEO, CFO, IRO. We gather deep sectorial management experience with extensive networks in Europe, Asia and Middle-East among industrials and finance key decision-makers.

Agile Capital Markets was set up by Eric Cohen, former CFO of public and private medical devices and biotechnologies companies, to deliver corporate financial & strategic advice to entrepreneurs in the life science industry. With more than 40 years cumulated within this industry and €300m secured in transactions in the recent years, Agile Capital Markets’ partners have a thorough expertise and an extensive professional network.

Agile Capital Markets’ partners are dedicated to provide advice to entrepreneurs in the life science industry to help them building their equity story and secure financial transactions that will bring them to the next stage.

Our background as C-Level executives within the industry is an insurance that we will be able to understand the challenges entrepreneurs are facing. Our aim is to build long term relationships with our clients and to play a key role in achieving financial milestones as well as building the most efficient strategy for our client.

Agile Capital Markets has built a team of passionate and committed professionals, with one singularity: they all show successful track records in the industry as private or listed companies’ CEO, CFO, IRO. We gather deep sectorial management experience with extensive networks in Europe, Asia and Middle-East among industrials and finance key decision-makers. 

SENIOR TEAM

Our Partners

Eric Cohen

Managing Director
eric.cohen@agilecapitalmarkets.com
Learn More

Sophie Baratte

Managing Director
sophie.baratte@agilecapitalmarkets.com
Learn More

SENIOR TEAM

Our Partners

Eric Cohen

Managing Director
eric.cohen@agilecapitalmarkets.com
Learn More

Sophie Baratte

Managing Director
sophie.baratte@agilecapitalmarkets.com
Learn More

SERVICES

What we do
Scope of clients

Agile Capital Markets provides strategic and financial advice for BioTech, Medtech, Digital Health, Diagnostic companies raising between €3M to €60+M in series A to C+.

Game changing innovations

We like to work with outstanding companies that develop healthcare products that will change life of thousands or millions of patients.

Full Services

Our services include but are not limited to: Capital raising of series A to C+, Merger & Acquisitions (buy side, sell side), Secondary offering, Strategic advice, Business model and Business planning.

International reach of healthcare investors

We are providing a wide access to the international investment community specialised in healthcare, covering Europe, North America and Asia.

+1000 investors can be reached

Strategic role

We work closely with the CEO and their management team to design the most efficient equity story, the one that will facilitate the fund raising process while optimising value creation for the stakeholders of the company. We are not afraid of providing advices on the business model, the regulatory strategies, the market access approach and the Commercial ramp-up options.

Strategic transactions / Business Development expertise

We use our long experience in these industries and our extended professional networks and negotiation skills to create strategic opportunities for our clients.

We are involved in M&A transactions or business developments activities.

NEWS

Transactions

CONTACT

33 rue Lafayette 75009 Paris

contact@agilecapitalmarkets.com

33 rue Lafayette
75009 Paris
contact@agilecapitalmarkets.com